Recombinant Human Osteoprotegerin (OPG)

Home/Recombinant Proteins/Recombinant Human Osteoprotegerin (OPG)

Pricing & Details

Product. No.O102
Alternate Names
TNFRSF11B, Osteoclast Inhibitory Factor (OCIF), MGC29565, TR1, OCIT
Expression Host
NS0 cells
Species
Human
Prod No.
Size
Price
Avail.
Qty
Add to cart
O102-25 µg
25 µg
$379.00
In stock
Max:
Min: 1
Step: 1

Background

Osteoprotegerin (OPG), also known as TNFRSF11B, is a cytokine and member of the TNF receptor superfamily that is expressed in a wide variety of tissues including adult heart, lung, kidney, liver, spleen, prostate, lymph node and bone marrow. OPG is an osteoblast-secreted decoy receptor that functions as a negative regulator of bone resorption.1 It specifically binds to its ligand, osteoprotegerin ligand (OPGL), which is a key extracellular regulator of osteoclast development. Therefore, OPG may provide a pharmacological tool for osteoporotic and erosive bone disorders. Studies also suggest this protein and its ligand play a role in lymph-node organogenesis and vascular calcification.4

Protein Details

Purity
>95% by SDS-PAGE and analyzed by silver stain.
Endotoxin Level
<0.1 EU/µg as determined by the LAL method
Biological Activity
The biological activity of Human OPG was determined by its ability to neutralize apoptosis of mouse L-929 cells treated with 20 ng/ml cross-linked soluble rhTRAIL. The expected ED50 for this effect is typically 8 - 24 ng/ml.
Expression Host
NS0 cells
Amino Acid Sequence
etfppkylh ydeetshqll cdkcppgtyl kqhctakwkt vcapcpdhyy tdswhtsdec lycspvckel qyvkqecnrt hnrvceckeg ryleiefclk hrscppgfgv vqagtpernt vckrcpdgff snetsskapc rkhtncsvfg llltqkgnat hdnicsgnse stqkcgidvt lceeaffrfa vptkftpnwl svlvdnlpgt kvnaesveri krqhssqeqt fqllklwkhq nkaqdivkki iqdidlcens vqrhighanl tfeqlrslme slpgkkvgae diektikack psdqilklls lwrikngdqd tlkglmhalk hsktyhfpkt vtqslkktir flhsftmykl yqklflemig nqvqsvkisc l
State of Matter
Lyophilized
Predicted Molecular Mass
The predicted molecular weight of each monomer of mature OPG(generated after removal of a 21 amino acid signal peptide) is Mr 43.5 kDa. However, the actual molecular weight as observed by migration on SDS-PAGE under reducing conditions, as a result of glycosylation, of recombinant Human OPG is Mr 55 kDa.
Formulation
This recombinant protein was 0.2 µm filtered and lyophilized from modified Dulbecco’s phosphate buffered saline (1X PBS) pH 7.2 – 7.3 with no calcium, magnesium, or preservatives.
Storage and Stability
This lyophilized protein is stable for six to twelve months when stored desiccated at -20°C to -70°C. After aseptic reconstitution, this protein may be stored at 2°C to 8°C for one month or at -20°C to -70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. See Product Insert for exact lot specific storage instructions.
Country of Origin
USA
Shipping
Next Day Ambient
NCBI Gene Bank

References & Citations

1. Cher, ML. et al. (2007) Am J Pathol. 170(6):2100-11. PubMed
2. Schoppet, M. et al. (1980) Arteriosclerosis, Thrombosis, & Vascular Biol. 22:549
3. Kurihara, H. et al. (2002) Cytokine 18:133
4. Dunstan, CR. et al. (2001) J. Bone Miner. Res. 16:348
5. Collin-Osdoby, P. et al. (2004) Circulation Res. 95:1046
IMPORTANT Use lot specific datasheet for all technical information pertaining to this recombinant protein.
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Leinco Technologies uses cookies to improve your experience and our website service. By continuing to browse our website, you accept our cookie policy. Ok